Abstract
Genomic innovation can give rise to many uncertainties. New uncertainties induced by genomic innovation change the room to maneuver and upset actor's behaviors, disrupting individual and collective strategies. A French case study shows that the new operational and organizational strategies have to upscale and pool some resources, and at the same time, enable competition and entrepreneurial freedom. Genomic innovation gives rise to new strategies and to organizational innovations, pointing to the need for regulatory innovation.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
